223 Pill - pink round, 10mm
Pill with imprint 223 is Pink, Round and has been identified as Lithium Carbonate Extended Release 300 mg. It is supplied by Glenmark Generics Inc.
Lithium is used in the treatment of Bipolar Disorder; Schizoaffective Disorder; Mania and belongs to the drug class antimanic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 223
Lithium Carbonate Extended Release
- Imprint
- 223
- Strength
- 300 mg
- Color
- Pink
- Size
- 10.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Antimanic agents
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Glenmark Generics Inc.
- National Drug Code (NDC)
- 68462-0223
- Inactive Ingredients
-
sodium chloride,
povidone k30,
sorbitol,
sodium starch glycolate type A potato,
calcium stearate,
sodium lauryl sulfate,
hypromellose 2910 (15000 mPa.s),
titanium dioxide,
polyethylene glycol 400,
ferric oxide red
Note: Inactive ingredients may vary.
Related images for "223"
More about lithium
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (480)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: antimanic agents
- Breastfeeding
- En español
Patient resources
- Lithium drug information
- Lithium Capsules and Tablets
- Lithium Controlled-Release and Extended-Release Tablets
- Lithium Syrup and Oral Solution
Other brands
Eskalith, Lithobid, Eskalith-CR
Professional resources
- Lithium monograph
- Lithium (FDA)
- Lithium Capsules (FDA)
- Lithium Carbonate (FDA)
- Lithium Carbonate ER Tablets (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
